Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine vs Sevoflurane for Pediatric Ophthalmological Sedation
NCT05011214Phase 4Unknown
- Sponsor
- Eye and ENT Hospital of Fudan University
- Start
- Sep 2021
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of esketamine in Procedural sedation (PS), sponsored by Eye and ENT Hospital of Fudan University. Primary endpoint: Eye position scale. Status: unknown.
02
Drugs
esketamine
03
Conditions
Procedural sedation (PS)
Beyond the preview
Go deeper on NCT05011214.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05011214.